BRIEF

on Viromed Medical AG (isin : DE000A3MQR65)

Viromed Medical AG Announces Changes to Management Board

Viromed Medical AG has announced a significant change to its Management Board. The Supervisory Board has appointed Christian Strauch as a new member, effective immediately. Strauch, with over two decades of experience in the healthcare sector, will serve until October 31, 2029. His expertise lies in building and scaling companies, which aligns with Viromed's strategic goals.

Additionally, Uwe Perbandt, the company's founder, will step down from his position on the Management Board for personal reasons. Perbandt's resignation will be effective from December 31, 2026. This transition marks a new phase for Viromed, as it balances experienced leadership with its ongoing growth strategy.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Viromed Medical AG news